Asako Minami

633 total citations
11 papers, 524 citations indexed

About

Asako Minami is a scholar working on Physiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Asako Minami has authored 11 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Asako Minami's work include Diabetes Treatment and Management (3 papers), Pancreatic function and diabetes (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Asako Minami is often cited by papers focused on Diabetes Treatment and Management (3 papers), Pancreatic function and diabetes (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Asako Minami collaborates with scholars based in Japan, Australia and China. Asako Minami's co-authors include Yutaka Nakaya, S. Sakamoto, Yasuharu Niwa, Nagakatsu Harada, Masaharu OHNAKA, Kazuhiro Kishi, Yousuke Ebina, Koichiro Tsuchiya, Kazuo Minakuchi and Hitoshi Houchi and has published in prestigious journals such as American Journal of Clinical Nutrition, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Asako Minami

11 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asako Minami Japan 10 201 198 135 133 95 11 524
Fanny Desjardins Belgium 14 250 1.2× 269 1.4× 126 0.9× 83 0.6× 69 0.7× 15 716
Neehar Gupta Canada 9 214 1.1× 190 1.0× 170 1.3× 79 0.6× 161 1.7× 18 572
Roman Judzewitsch United States 8 207 1.0× 137 0.7× 157 1.2× 156 1.2× 277 2.9× 10 615
Morihiko Maeda Japan 9 205 1.0× 128 0.6× 61 0.5× 40 0.3× 79 0.8× 10 532
Naohito Ishii Japan 16 188 0.9× 148 0.7× 71 0.5× 34 0.3× 119 1.3× 38 703
Agnieszka Mikłosz Poland 14 231 1.1× 304 1.5× 106 0.8× 101 0.8× 85 0.9× 41 587
Fumi Sawada Japan 9 128 0.6× 117 0.6× 166 1.2× 36 0.3× 100 1.1× 10 445
David J. Pedersen Australia 12 379 1.9× 277 1.4× 154 1.1× 173 1.3× 116 1.2× 14 794
Firoozeh Salehzadeh Sweden 10 250 1.2× 184 0.9× 48 0.4× 61 0.5× 74 0.8× 12 466
J S Zhu United States 7 358 1.8× 507 2.6× 273 2.0× 100 0.8× 167 1.8× 8 937

Countries citing papers authored by Asako Minami

Since Specialization
Citations

This map shows the geographic impact of Asako Minami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asako Minami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asako Minami more than expected).

Fields of papers citing papers by Asako Minami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asako Minami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asako Minami. The network helps show where Asako Minami may publish in the future.

Co-authorship network of co-authors of Asako Minami

This figure shows the co-authorship network connecting the top 25 collaborators of Asako Minami. A scholar is included among the top collaborators of Asako Minami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asako Minami. Asako Minami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liu, Limei, Hiroto Furuta, Asako Minami, et al.. (2007). A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family. Molecular and Cellular Biochemistry. 303(1-2). 115–120. 35 indexed citations
2.
Obata, Toshiyuki, Rie Matsushima, Asako Minami, et al.. (2004). KATP Channel Knockout Mice Crossbred with Transgenic Mice Expressing a Dominant-negative Form of Human Insulin Receptor Have Glucose Intolerance but not Diabetes. Endocrine Journal. 51(2). 133–144. 12 indexed citations
3.
Minami, Asako, Masanori Iseki, Kazuhiro Kishi, et al.. (2003). Increased Insulin Sensitivity and Hypoinsulinemia in APS Knockout Mice. Diabetes. 52(11). 2657–2665. 76 indexed citations
4.
Harada, Nagakatsu, et al.. (2002). Combined effect of ACE inhibitor and exercise training on insulin resistance in type 2 diabetic rats. Life Sciences. 70(15). 1811–1820. 12 indexed citations
6.
7.
Houchi, Hitoshi, Asako Minami, S. Sakamoto, et al.. (2001). Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sciences. 69(15). 1709–1715. 63 indexed citations
8.
Kishi, Kazuhiro, Tomoyuki Yuasa, Asako Minami, et al.. (2000). AMP-Activated Protein Kinase Is Activated by the Stimulations of Gq-Coupled Receptors. Biochemical and Biophysical Research Communications. 276(1). 16–22. 54 indexed citations
9.
Nakaya, Yutaka, Asako Minami, Nagakatsu Harada, et al.. (2000). Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. American Journal of Clinical Nutrition. 71(1). 54–58. 155 indexed citations
10.
Hara, Tsutomu, Masataka Kusunoki, Asako Minami, et al.. (2000). Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats. Metabolism. 49(5). 588–593. 6 indexed citations
11.
Nakaya, Yutaka, Asako Minami, S. Sakamoto, et al.. (1999). Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long‐Evans Tokushima Fatty Rat, a model of spontaneous NIDDM. Diabetes Obesity and Metabolism. 1(1). 37–41. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026